1/3

FIEO Registered Export Ready

Bromocriptine Mesylate Tablets IP 2.5 mg

Name: Bromocriptine Mesylate Tablets IP 2.5 mg
Brand: indiglobal exports
SKU: 8520295
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Bromocriptine Mesylate Tablets IP 2.5 mg is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of gynecology conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Gynecology Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Bromocriptine Mesylate Tablets IP 2.5 mg is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Product Category	Gynecology
Formulation	Tablet
Active Pharmaceutical Ingredient (API)	Bromocriptine Mesylate IP 2.5 mg
Packaging Details	Export-grade blister or strip packaging
Shelf Life Duration	As per regulatory standards (usually 24 months)
Storage Conditions	Store in a cool, dry place away from light
Compliance	WHO-GMP and Indian Pharmacopoeia IP standards
Manufacturer Name	IndiGlobal Exports
Intended Use	Treatment of hormone-related gynecology conditions
Dosage and Administration	Orally administered as per physician’s prescription

Use cases

Category	Pharmaceuticals > Gynecology Medicines > Bromocriptine Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Bromocriptine Mesylate Tablets IP 2.5 mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is the Bromocriptine Mesylate Tablets IP 2.5 mg suitable for export to regulated pharmaceutical markets?

A: Yes, these tablets are manufactured under WHO-GMP certified facilities and comply with Indian Pharmacopoeia standards, making them suitable for export to both regulated and semi-regulated markets.

Q: What gynecological conditions can Bromocriptine Mesylate Tablets IP 2.5 mg treat effectively?

A: This formulation is indicated for managing hormone-related gynecological disorders such as hyperprolactinemia, amenorrhea, and other menstrual irregularities.

Q: How is the dosage of Bromocriptine Mesylate Tablets ensured to be precise?

A: Each tablet is manufactured in a controlled environment with exacting pharmaceutical standards to provide consistent 2.5 mg dosing of Bromocriptine Mesylate.

Q: What packaging options are available for this product suited for institutional buyers?

A: The tablets are packaged in export-grade blisters or strip packs designed for bulk supply and institutional pharmaceutical distribution.

Q: Does this product meet international quality and safety standards?

A: Yes, it adheres strictly to Indian Pharmacopoeia (IP) quality standards and is produced in GMP-compliant facilities aligned with WHO guidelines.

Question not answered? Ask sellers directly — typical response within 4 hours.